PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Statistics

Total Valuation

ASX:PYC has a market cap or net worth of AUD 1.41 billion. The enterprise value is 1.29 billion.

Market Cap	1.41B
Enterprise Value	1.29B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:PYC has 941.49 million shares outstanding. The number of shares has increased by 27.16% in one year.

Current Share Class	941.49M
Shares Outstanding	941.49M
Shares Change (YoY)	+27.16%
Shares Change (QoQ)	+14.51%
Owned by Insiders (%)	23.75%
Owned by Institutions (%)	5.93%
Float	587.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	68.46
PB Ratio	9.55
P/TBV Ratio	9.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.08
EV / Sales	62.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.45

Financial Position

The company has a current ratio of 13.96, with a Debt / Equity ratio of 0.01.

Current Ratio	13.96
Quick Ratio	13.92
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-906.21

Financial Efficiency

Return on equity (ROE) is -47.55% and return on invested capital (ROIC) is -31.80%.

Return on Equity (ROE)	-47.55%
Return on Assets (ROA)	-28.68%
Return on Invested Capital (ROIC)	-31.80%
Return on Capital Employed (ROCE)	-35.22%
Weighted Average Cost of Capital (WACC)	9.13%
Revenue Per Employee	4.11M
Profits Per Employee	-9.51M
Employee Count	5
Asset Turnover	0.18
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.55% in the last 52 weeks. The beta is 0.89, so ASX:PYC's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+21.55%
50-Day Moving Average	1.58
200-Day Moving Average	1.34
Relative Strength Index (RSI)	41.15
Average Volume (20 Days)	1,395,180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PYC had revenue of AUD 20.56 million and -47.56 million in losses. Loss per share was -0.09.

Revenue	20.56M
Gross Profit	20.56M
Operating Income	-52.17M
Pretax Income	-48.27M
Net Income	-47.56M
EBITDA	-51.41M
EBIT	-52.17M
Loss Per Share	-0.09

Balance Sheet

The company has 120.69 million in cash and 827,083 in debt, with a net cash position of 119.86 million or 0.13 per share.

Cash & Cash Equivalents	120.69M
Total Debt	827,083
Net Cash	119.86M
Net Cash Per Share	0.13
Equity (Book Value)	147.33M
Book Value Per Share	0.25
Working Capital	142.73M

Cash Flow

In the last 12 months, operating cash flow was -65.75 million and capital expenditures -463,795, giving a free cash flow of -66.22 million.

Operating Cash Flow	-65.75M
Capital Expenditures	-463,795
Free Cash Flow	-66.22M
FCF Per Share	-0.07

Margins

Gross margin is 100.00%, with operating and profit margins of -253.75% and -231.33%.

Gross Margin	100.00%
Operating Margin	-253.75%
Pretax Margin	-234.77%
Profit Margin	-231.33%
EBITDA Margin	-250.05%
EBIT Margin	-253.75%
FCF Margin	n/a

Dividends & Yields

ASX:PYC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.16%
Shareholder Yield	-27.16%
Earnings Yield	-3.38%
FCF Yield	-4.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 15, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 15, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:PYC has an Altman Z-Score of 33.85 and a Piotroski F-Score of 1.

Altman Z-Score	33.85
Piotroski F-Score	1